MedPacto, Inc. (KOSDAQ:235980)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,110.00
+50.00 (1.63%)
Apr 1, 2025, 3:30 PM KST

MedPacto Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
3,6134,4275,0214,6073,535
Research & Development
18,01824,16431,91924,55123,962
Other Operating Expenses
---12.4613.91
Operating Expenses
21,80728,75237,24629,45927,800
Operating Income
-21,807-28,752-37,246-29,459-27,800
Interest Expense
-91.94-493.23-9,621-7,769-31.27
Interest & Investment Income
1,687388.461,324663.52508.79
Earnings From Equity Investments
-424.3-390.44---248.59
Currency Exchange Gain (Loss)
-116.09114.0925.05-19.66-146.41
Other Non Operating Income (Expenses)
85.464.079,27219,278151.9
EBT Excluding Unusual Items
-20,667-29,069-36,246-17,306-27,566
Gain (Loss) on Sale of Investments
526.5350.51492.28266.332,213
Gain (Loss) on Sale of Assets
--5.93---
Other Unusual Items
--6,600---
Pretax Income
-20,140-35,325-35,753-17,040-25,352
Net Income
-20,140-35,325-35,753-17,040-25,352
Net Income to Common
-20,140-35,325-35,753-17,040-25,352
Shares Outstanding (Basic)
3421332020
Shares Outstanding (Diluted)
3421332020
Shares Change (YoY)
58.75%-36.21%62.45%0.88%-
EPS (Basic)
-598.00-1665.00-1075.00-832.30-1249.24
EPS (Diluted)
-598.00-1665.00-1075.00-832.30-1249.24
Free Cash Flow
-16,873-26,402-30,491-25,909-24,100
Free Cash Flow Per Share
-500.99-1244.42-916.79-1265.52-1187.53
EBITDA
-20,265-26,919-35,380-27,736-26,363
D&A For EBITDA
1,5421,8331,8661,7231,437
EBIT
-21,807-28,752-37,246-29,459-27,800
Source: S&P Global Market Intelligence. Standard template. Financial Sources.